ChartMill assigns a fundamental rating of 5 / 10 to CBPO.
ChartMill assigns a valuation rating of 2 / 10 to China Biologic Produ (CBPO). This can be considered as Overvalued.
China Biologic Produ (CBPO) has a profitability rating of 6 / 10.
The Earnings per Share (EPS) of China Biologic Produ (CBPO) is expected to grow by 7.77% in the next year.
The dividend rating of China Biologic Produ (CBPO) is 0 / 10 and the dividend payout ratio is 8.12%.